Gallbladder adenocarcinoma: prognostic significance of tumor acid mucopolysaccharide content. 1986

L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel

The gall bladder mucosa is composed of neutral mucopolysaccharide and protein radical containing secretory cells, protein radical containing migratory cells, and neutral and acid mucopolysaccharides plus sialic acid containing goblet cells. The prognostic significance of histologic or histochemical parameters in gall bladder adenocarcinoma (GBA) are unknown. To determine if histochemical acid mucopolysaccharide content in GBA has prognostic value, GBA histologic sections from 26 advanced stage disease patients participating in Eastern Cooperative Oncology Group (ECOG) treatment study EST-2273 were stained with alcian blue at pH. 1.0, assessed by a pathology panel for either high (greater than 50%) or low (less than 50%) acid mucopolysaccharide content, and correlated with patient survival. Initial panel unanimous concurrence rate on acid mucopolysaccharide content was 88.9%. Median survival times from the start of chemotherapy to date of death for high acid mucopolysaccharide content GBA was 14 weeks versus five weeks for the low content GBA (P less than 0.0001). The results indicate that high acid mucopolysaccharide content in GBA significantly improves prognosis. ECOG recommends stratification by acid mucopolysaccharide content in future GBA treatment investigations.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005706 Gallbladder Neoplasms Tumors or cancer of the gallbladder. Cancer of Gallbladder,Gallbladder Cancer,Cancer of the Gallbladder,Gall Bladder Cancer,Neoplasms, Gallbladder,Bladder Cancer, Gall,Bladder Cancers, Gall,Cancer, Gall Bladder,Cancer, Gallbladder,Cancers, Gall Bladder,Cancers, Gallbladder,Gall Bladder Cancers,Gallbladder Cancers,Gallbladder Neoplasm,Neoplasm, Gallbladder
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D006651 Histocytochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. Cytochemistry
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000423 Alcian Blue A copper-containing dye used as a gelling agent for lubricants, for staining of bacteria and for the dyeing of histiocytes and fibroblasts in vivo. Alcian Blue 8GS,Alcian Blue 8GX,8GS, Alcian Blue,8GX, Alcian Blue,Blue 8GS, Alcian,Blue 8GX, Alcian,Blue, Alcian

Related Publications

L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
January 2017, Neoplasma,
L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
November 2014, Gynecologic oncology,
L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
October 1990, Analytical and quantitative cytology and histology,
L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
June 1992, The Journal of thoracic and cardiovascular surgery,
L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
January 1960, Circulation research,
L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
March 1970, Journal of animal science,
L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
January 2003, Anticancer research,
L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
June 1998, International journal of radiation oncology, biology, physics,
L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
August 2004, Journal of cancer research and clinical oncology,
L A Johnson, and P T Lavin, and Y Y Dayal, and S A Geller, and W G Doos, and H S Cooper, and J E Gerber, and S T Masse, and L H Weiland, and C G Moertel
April 1966, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!